Categories: News

Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2022, before the open of the financial markets on Thursday, May 5, 2022.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Interim Chief Financial Officer, will host a conference call on Thursday, May 5 at 9:00 AM ET to review results.

Conference Details
Conference Date: Thursday, May 5, 2022 – 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q1 2022 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com

Staff

Recent Posts

AllianceHCM Appoints Alan Primeaux as Chief Executive Officer to Propel Next Phase of Growth

HOUSTON, June 24, 2025 /PRNewswire/ -- AllianceHCM, one of the nation's leading privately held providers…

1 hour ago

Kicking Off Today! Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston — shaping biomanufacturing’s future

Sartorius launches a premier industry event focused on process intensification (PI) for protein therapeutics and…

1 hour ago

Label-free Detection Market to Accelerate Growth from USD 2.64 Billion to USD 4.48 Billion by 2032 – Meticulous Research®

Rising Pharmaceutical Innovation, AI Integration, and Point-of-Care Testing Applications Drive 9.8% CAGR Growth Across Healthcare…

1 hour ago

Careington Implements Cognigy’s Voice AI Solution to Elevate Customer Service Capabilities

FRISCO, Texas, June 24, 2025 /PRNewswire/ -- Careington International Corporation is proud to announce enhanced customer…

1 hour ago

Quicken Survey Reveals How Natural Disasters, Medical Costs, Job Loss, and Insurance Gaps Impact Personal Finances

While Americans are confident in their ability to handle regular financial obligations, unexpected expenses reveal gaps…

1 hour ago